Quick Facts

• Relief Domain: Temporary management of common cold and influenza symptoms.
• Symptom Areas: Helps address fever, minor aches, headache, and nasal congestion.
• Primary Benefit: Supports comfort and symptom management during illness episodes.

---

What Lemsip Max Sinus Treats: Main Uses and Benefits

Lemsip Max Sinus is typically used to provide temporary relief from the familiar symptoms associated with colds and influenza. The medication is an option for addressing fever and minor aches and pains that frequently occur during these illnesses. It can help reduce an elevated body temperature and support overall patient comfort.

The formulation also offers support for nasal congestion and sinus pressure. It is designed to help diminish swelling in the nasal passages, which facilitates easier breathing and may offer improvement of related pressure and discomfort in the head and face. The product provides a measure of relief for a sore throat and headache that accompany cold and flu episodes.

This medication is solely intended for the temporary management of symptoms and does not address the underlying cause or duration of the illness. Consultation with a healthcare professional is recommended if symptoms persist or worsen.

Eligibility for Use

Approved Populations: The medicine is officially indicated for use by Adults and Children aged 16 years and over. Normal adult usage is generally considered appropriate for the elderly population, though regulatory labeling advises a potential reduction in the amount or frequency for frail, immobile, or older subjects with organ impairment.

Pediatric Exclusion: Use is strictly contraindicated for children under 16 years of age.

Absolute Contraindications

The product must not be used by individuals with the following official contraindications, as stated in regulatory documents:

• Cardiovascular/Endocrine: Severe coronary heart disease, hypertension (high blood pressure), hyperthyroidism, or diabetes mellitus.
• Ocular/Adrenal/Urological: Closed-angle glaucoma, phaeochromocytoma, or prostatic enlargement.
• Concomitant Therapy: Patients currently receiving or within two weeks of stopping therapy with Monoamine Oxidase Inhibitors (MAOIs), or those using other sympathomimetic decongestants.

Condition-Based Restrictions

Official labeling advises that care is necessary when administering this medicine to patients with severe renal impairment or severe hepatic impairment. Use should also be avoided in patients with non-cirrhotic alcoholic liver disease due to an increased hazard of overdose.

Pregnancy and Lactation Status

Use is not recommended during either pregnancy or lactation unless specifically advised by a healthcare professional. Use during pregnancy should be avoided due to a possible association with fetal abnormalities linked to phenylephrine exposure in the first trimester, and it is contraindicated in patients with a history of pre-eclampsia.

Interactions with other medicines and products

Official regulatory documentation identifies several clinically significant interaction patterns based on the product’s multi-ingredient composition.

Contraindicated and High-Risk Combinations

The product is strictly contraindicated for co-administration with Monoamine Oxidase Inhibitors (MAOIs), including Moclobemide, or within 14 days of stopping MAOI therapy, as hypertensive interactions occur. Co-use with other sympathomimetic amines (e.g., other decongestants) and other paracetamol-containing products is also restricted.

Pharmacodynamic and Metabolic Effects

The Phenylephrine component may officially reduce the efficacy of beta-blockers and other antihypertensives. The risk of cardiovascular side effects may be increased by co-use with Tricyclic Antidepressants or Cardiac Glycosides (e.g., Digoxin). Furthermore, Liver Enzyme-Inducing Drugs (e.g., certain anticonvulsants) and Alcohol may increase the hepatotoxic potential of Acetaminophen. The anticoagulant effect of Warfarin and other Coumarins may be enhanced by prolonged, regular use of Acetaminophen.

Exposure Modification and Timing Constraints

The absorption rate of Acetaminophen may be increased by agents such as Metoclopramide or Domperidone. Conversely, the absorption may be reduced by Cholestyramine, which mandates a separation rule: Acetaminophen must be taken at least one hour before or four to six hours after Cholestyramine. Caution is additionally noted regarding the greater hazard of overdose in patients with non-cirrhotic alcoholic liver disease.

The pharmacological effect of this fixed-dose combination arises from three distinct, yet complementary, mechanistic domains, targeting specific enzyme and receptor systems to modulate defined biological pathways.

Central Inhibition of Prostaglandin Synthesis

This mechanism involves Acetaminophen acting as an inhibitor of Cyclooxygenase (COX) enzymes, primarily within the central nervous system. This action reduces the central synthesis of Prostaglandin E2 ( PGE2), a crucial mediator that elevates the body's thermoregulatory set-point and amplifies nociceptive signals. The resulting physiological effect is a resetting of the hypothalamic thermal set-point and an attenuation of central nociceptive pathway transmission.

---

Sympathetic alpha1-Adrenergic Receptor Activation

The vasoconstrictive mechanism is driven by Phenylephrine, an agonist of alpha1-adrenergic receptors located on the blood vessels in the nasal mucosa. Activating these receptors initiates a vasoconstrictive cascade, reducing local blood flow and volume in the nasal lining. This physiological adjustment leads to a reduction in mucosal interstitial fluid volume. This alpha1-agonist mechanism, however, is functionally constrained by the low oral bioavailability of the compound.

---

Antagonism of CNS Adenosine Pathways

Caffeine contributes by acting as an antagonist of Adenosine Receptors in the central nervous system, effectively removing Adenosine's inhibitory influence on neuronal activity. This process of CNS disinhibition increases the release of excitatory neurotransmitters, resulting in the disinhibition of CNS neuronal activity and increased wakefulness. Furthermore, this central action enhances the central analgesic effect of Acetaminophen through a recognized synergistic mechanism.

How to Use Lemsip Max Sinus: Administration Guidelines

This section outlines the instructions for using Lemsip Max Sinus, a fixed-dose combination product containing acetaminophen (paracetamol) and phenylephrine.

Dosing and Administration Protocol

The medicine is administered via the oral route as a hot drink, following dissolution in water. The dosing regimen is specific and is followed to ensure appropriate use.

Usage Parameter	Standard Instruction
Dose per Intake	Content of one sachet
Minimum Interval	4 hours between doses
Maximum Daily Dose	Do not take more than 4 sachets in 24 hours
Approved Population	Adults, the elderly, and children aged 16 years and over
Duration of Use	Consult a healthcare professional if symptoms persist for more than 5 days

Preparation and Intake Instructions

The product is prepared immediately prior to use. The contents of one sachet should be dissolved in a mug of hot, but not boiling, water and stirred until the powder is fully dissolved. The final solution may be sweetened to taste, if preferred. The dose should be repeated only as needed, ensuring the minimum 4-hour interval is maintained. The medicine is not recommended for children under 16 years of age.

Research on Symptom Relief

Randomized controlled trials (RCTs) have been applied in research exploring how symptoms change over time for the core components of this medicine, including the analgesic and antipyretic (Acetaminophen). These studies were used in research contexts involving fluctuating or unstable symptoms, such as the common cold or flu-like illness. Research examined how patients reported changes in outcomes related to physical discomfort, including headache, fever, and general body aches. Findings describe patterns observed in the studies related to temporary measured values for fever and pain outcomes. Research examined whether combining the analgesic component with other ingredients provides additional insight into overall symptom patterns. Follow-up durations were limited, providing insight into short-term changes but not extended outcomes over the full course of an illness.

---

Nasal Congestion and Research Uncertainty

Research has explored the decongestant component, Phenylephrine, in studies monitoring outcomes related to functional imbalance, specifically the ability to breathe through the nose. Multiple authoritative systematic reviews have explored the data, and findings were mixed regarding the component's measured change in symptoms compared to a placebo (an inactive substance) when used orally at the standard dose (e.g., 10 mg). Studies monitored whether the component, at this standard dose, may be distinguishable from placebo on the measured outcomes related to decongestion. The certainty remains low on its decongestant study outcomes in the context of the common cold, and more comparative evidence is lacking.

---

Alertness and Limitations

The Caffeine component was studied for measured change in outcomes related to fatigue and alertness, exploring whether the component was associated with measured changes in alertness assessments. Much of the evidence is short-term, meaning data for long-term outcomes following repeated or extended use is limited. Data for certain special groups, such as older adults, children, or individuals with pre-existing conditions, also remain insufficient. Comparative evidence against other single-ingredient or fixed-dose formulations remains an area of research where published literature is limited.

Common questions about Lemsip Max Sinus (FAQ)

Q: What should I do if my cold symptoms don't improve after taking this medicine?

Official administration guidelines state that this medicine is for short-term use. If symptoms, such as headache or congestion, persist or do not show improvement after 5 days of treatment, official guidance is that a healthcare professional should be consulted.

Q: How does Lemsip Max Sinus work to relieve my symptoms?

This product is a fixed-dose combination containing three active ingredients. Acetaminophen works to relieve general aches and reduce fever. Phenylephrine acts as a decongestant to help clear a blocked nose. The caffeine content is included to help counteract the tiredness and fatigue often associated with cold and flu.

Q: What are the serious side effects I should be aware of?

Regulatory safety information indicates that serious side effects are rare. These can include severe skin reactions, such as Acute Generalized Exanthematous Pustulosis, or blood disorders. Official warnings highlight that immediate medical advice should be sought if symptoms of allergic reactions, high blood pressure with a severe headache, or signs of liver damage occur.

Q: Can I take this if I am pregnant or breastfeeding?

Official regulatory documents state that the use of this product is generally not recommended during pregnancy or while breastfeeding. It should be avoided unless a healthcare professional has specifically advised its use.

Q: Are there any foods or drinks I should avoid while taking this?

Official product information advises against taking this medicine with large quantities of alcohol, as it may increase the hepatotoxic risk associated with acetaminophen. Due to the caffeine content in this medicine, official warnings also advise against excessive intake of other caffeinated beverages (like coffee or tea) to reduce the risk of side effects such as palpitations.

Q: Can I take Lemsip Max Sinus if I have asthma?

Official warnings state that this product should not be used to treat a persistent or chronic cough associated with conditions such as asthma. If there is a history of asthma or another respiratory condition, official guidelines state that consultation with a doctor is necessary before use.

Q: Is it safe to drive after taking Lemsip Max Sinus?

Regulatory documents indicate that this medicine may cause side effects such as dizziness, restlessness, or mental confusion in some users. If individuals experience these effects, official advice is that they should not drive or operate machinery.

Q: What should I do if I accidentally take two sachets at once?

Taking more than the recommended dose can be dangerous, particularly due to the acetaminophen content. Official overdose guidance strongly recommends that immediate medical advice or attention be sought in the event of an overdose, even if the individual feels well, as the risk of serious, delayed liver damage is present.

How to Store and Dispose of Lemsip Max Sinus

The storage and disposal of Lemsip Max Sinus must adhere to official regulatory requirements to ensure product integrity and environmental protection.

Official Storage Conditions

The medicine must be stored strictly not above 25°C. For product stability and protection, it is required to store Lemsip Max Sinus in the original package and often in a dry place. The product must not be used after the expiry date (EXP) stated on the carton.

Child Safety and Disposal

All regulatory labeling mandates that the medicine be kept out of the sight and reach of children.

For disposal, unused or expired medicine should not be discarded via wastewater or household waste. Regulatory guidelines state that patients must ask a pharmacist how to dispose of any medicines no longer required, as these measures help protect the environment.